Search Results

51 articles with title/keywords/abstract containing 5-reductase inhibitor

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Display per page 

Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery

Authors: Naslund, Michael; Eaddy, Michael T.; Hogue, Susan L.; Kruep, Eric J.; Shah, Manan B.

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2663-2669(7)

Publisher: Informa Healthcare

Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase

Authors: Vis, André N.; Schröder, Fritz H.

Source: BJU International, Volume 104, Number 9, November 2009 , pp. 1191-1197(7)

Publisher: Blackwell Publishing

Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Authors: Rosen, Raymond C.; Fitzpatrick, John M.

Source: BJU International, Volume 104, Number 7, October 2009 , pp. 974-983(10)

Publisher: Blackwell Publishing

Aromatic esters of progesterone as 5α-reductase and prostate growth inhibitors

Authors: Bratoeff, Eugene; Segura, Tania; Recillas, Sergio; Carrizales, Eric; Palacios, Anay; Heuze, Ivonne; Cabeza, Marisa

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 24, Number 3, June 2009 , pp. 655-662(8)

Publisher: Informa Healthcare

Prostate cancer: a serious disease suitable for prevention

Authors: Fitzpatrick, John M.; Schulman, Claude; Zlotta, Alexandre R.; Schröder, Fritz H.

Source: BJU International, Volume 103, Number 7, April 2009 , pp. 864-870(7)

Publisher: Blackwell Publishing

Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

Authors: Schröder, Fritz H.; Bangma, Chris H.; Wolff, Johannes M.; Alcaraz, Antonio; Montorsi, Francesco; Mongiat-Artus, Pierre; Abrahamsson, Per-Anders; McNicholas, Tom A.; Castro, Ramiro S.; Nandy, Indrani M.

Source: BJU International, Volume 103, Number 5, March 2009 , pp. 590-596(7)

Publisher: Blackwell Publishing

Neurosteroids and epileptogenesis in the pilocarpine model: Evidence for a relationship between P450scc induction and length of the latent period

Authors: Biagini, Giuseppe; Longo, Daniela; Baldelli, Enrica; Zoli, Michele; Rogawski, Michael A.; Bertazzoni, Giuliano; Avoli, Massimo

Source: Epilepsia, Volume 50, Supplement 1, January 2009 , pp. 53-58(6)

Publisher: Blackwell Publishing

Chemoprevention of prostate cancer: agents, studies and future prospects

Authors: Yafi, Faysal A; Aprikian, Armen G; Kassouf, Wassim

Source: Aging Health, Volume 4, Number 5, October 2008 , pp. 469-479(11)

Publisher: Future Medicine

Expression of E-SOD, GPX5 mRNAs and immunoexpression of Cu/ZnSOD in epididymal epithelial cells of finasteride-treated rats

Authors: Kolasa, A.; Marchlewicz, M.; Adler, G.; Ciechanowicz, A.; Głąbowski, W.; Wiszniewska, B.

Source: Andrologia, Volume 40, Number 5, October 2008 , pp. 303-311(9)

Publisher: Blackwell Publishing

Inhibition of 5α-Reduced Steroid Biosynthesis Impedes Acquisition of Ethanol Drinking in Male C57BL/6J Mice

Authors: Ford, Matthew M.; Yoneyama, Naomi; Strong, Moriah N.; Fretwell, Andrea; Tanchuck, Michelle; Finn, Deborah A.

Source: Alcoholism Clinical and Experimental Research, Volume 32, Number 8, August 2008 , pp. 1408-1416(9)

Publisher: Blackwell Publishing

The REDUCE trial: chemoprevention in prostate cancer using a dual 5α-reductase inhibitor, dutasteride

Authors: Musquera, Mireia; Fleshner, Neil E; Finelli, Antonio; Zlotta, Alexandre R

Source: Expert Review of Anticancer Therapy, Volume 8, Number 7, July 2008 , pp. 1073-1079(7)

Publisher: Expert Reviews

Investigation of the anticonvulsive effect of acute immobilization stress in anxious Balb/cByJ mice using GABAA-related mechanistic probes

Authors: Verleye, Marc; Heulard, Isabelle; Gillardin, Jean-Marie

Source: Psychopharmacology, Volume 197, Number 4, May 2008 , pp. 523-534(12)

Publisher: Springer

Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries

Authors: Fourcade, Richard-Olivier; Théret, Nathalie; Taïeb, Charles

Source: BJU International, Volume 101, Number 9, May 2008 , pp. 1111-1118(8)

Publisher: Blackwell Publishing

Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old

Authors: Camacho, F.M.; García-Hernández, M.J.; Fernández-Crehuet, J.L.

Source: British Journal of Dermatology, Volume 158, Number 5, May 2008 , pp. 1121-1124(4)

Publisher: Blackwell Publishing

BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE

Author: Roehrborn, Claus G.

Source: BJU International, Volume 101, Supplement 3, March 2008 , pp. 17-21(5)

Publisher: Blackwell Publishing

Dutasteride: A Review of its Use in the Management of Prostate Disorders

Authors: Keam, Susan J.; Scott, Lesley J.

Source: Drugs, Volume 68, Number 4, 2008 , pp. 463-485(23)

Publisher: Adis International

Free Content Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice

Authors: Eva, Carola; Mele, Paolo; Collura, Devis; Nai, Antonella; Pisu, Maria Giuseppina; Serra, Mariangela; Biggio, Giovanni

Source: Journal of Neurochemistry, Volume 104, Number 4, February 2008 , pp. 1043-1054(12)

Publisher: Blackwell Publishing

Biocatalytic synthesis of 4-pregnen-20,21-diol-3-one, a selective inhibitor of human 5α-reductase type II

Authors: Hannemann, Frank; Bernhardt, Rita; Jose, Joachim

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 22, Number 5, October 2007 , pp. 570-576(7)

Publisher: Informa Healthcare

Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5α-reductase inhibitor

Authors: Lu, Ying-Li; Kuang, Lin; Zhu, Hui; Wu, Hui; Wang, Xue-Fang; Pang, Yu-Ping; Wang, Ning-Jian; Yu, Dan-Lu

Source: Asian Journal of Andrology, Volume 9, Number 6, November 2007 , pp. 843-847(5)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A